Altamedics

Koln, Germany Acquired By Abiogen Pharma
Diversified drugs are distributed by Altamedics in Germany.

About Altamedics

Altamedics is a Healthcare company based in Koln (Germany), and was acquired by Abiogen Pharma in December 2022. Diversified drugs are distributed by Altamedics in Germany. The company has 6 employees. Altamedics offers products and services including Adenosin Altamedics 3 mg/ml, Flucloxacillin Altamedics 500 mg, Nipruss 60 mg, Nubain 10 mg/ml, and Sucrose 24%. Its focus areas include Pharmaceutical Distributors and Diversified. Its legal entity is ALTAMEDICS GmbH. Its competitors include CHEPLAPHARM, PHOENIX group and MEDI-MARKT.

Company details

A range of pharmaceutical products is distributed by Altamedics, with operations centered in Cologne, Germany. The company functions within the healthcare sector, focusing on logistics and supply chain management for diversified medications. Regional markets are served through established distribution networks, ensuring availability of essential drugs. No specific founding details are recorded, but activities remain aligned with pharmaceutical wholesale standards in Europe.

  • Headquarters Koln, Germany
  • Employees 6
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website altamedics.de/en-us
  • Acquired by Abiogen Pharma (Dec 2022)
  • Legal Name Altamedics Gmbh
Key Metrics

Products & Services of Altamedics

Altamedics offers a comprehensive portfolio of products and services, including Adenosin Altamedics 3 mg/ml, Flucloxacillin Altamedics 500 mg, Nipruss 60 mg, Nubain 10 mg/ml, and Sucrose 24%.

Adenosin Altamedics 3 mg/ml
Solution for Injection

Injection solution used for medical treatments and cardiovascular applications.

Flucloxacillin Altamedics 500 mg
Antibiotic Capsule

Hard capsule for treating bacterial infections in healthcare settings.

Nipruss 60 mg
Powder for Infusion

Powder converted to solution for infusion in emergency medical scenarios.

Nubain 10 mg/ml
Solution for Injection

Injection for pain management and analgesic purposes in clinics.

Sucrose 24%
Drinking Vial

Vial solution for nutritional or therapeutic uses in patient care.

Investors in Altamedics

Altamedics has secured backing from 1 investor. Prominent investors backing the company include Abiogen Pharma.

All
InvestorDescriptionFounded YearDomainLocation
Abiogen Pharma is engaged in pharmaceutical development and manufacturing.
1997abiogen.itPisa, Italy
Premium access

Investor details for Altamedics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Competitors of Altamedics

Altamedics has 3 listed competitors in our database. They include CHEPLAPHARM, PHOENIX group and MEDI-MARKT.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cheplapharm.com1998Mesekenhagen, Germany840
Branded pharmaceutical products are developed, marketed, and distributed globally.
phoenixgroup.eu1994Frankfurt Am Main, Germany128
Leading European provider of pharmaceutical wholesale, retail, and supply chain services.
medi-markt-profi.de1980Mannheim, Germany275
Online platform for the procurement of medical equipment
Premium access

Detailed competitors of Altamedics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Altamedics

Websites that share an audience with Altamedics (altamedics.de).

Similar websites

Websites whose visitors overlap most with Altamedics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
youtube.com
100%
30.4B#2View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Altamedics

Abiogen Pharma acquires Altamedics
Prnewswire β€’ 3 years ago
Premium access

Complete news archive for Altamedics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Altamedics

Altamedics is headquartered in Koln, Germany. It is registered at Koln, North Rhine-westphalia, Germany.

Altamedics has 6 employees.

A range of pharmaceutical products is distributed by Altamedics, with operations centered in Cologne, Germany. The company functions within the healthcare sector, focusing on logistics and supply chain management for diversified medications. Regional markets are served through established distribution networks, ensuring availability of essential drugs. No specific founding details are recorded, but activities remain aligned with pharmaceutical wholesale standards in Europe.

Altamedics's top competitors include CHEPLAPHARM, MEDI-MARKT and PHOENIX group.

Altamedics offers Adenosin Altamedics 3 mg/ml, Flucloxacillin Altamedics 500 mg, Nipruss 60 mg, Nubain 10 mg/ml, and Sucrose 24%.

Altamedics has 1 investor. Key investors include Abiogen Pharma.

Altamedics operates through Altamedics Gmbh.

Yes. Altamedics was acquired by Abiogen Pharma in December 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available